Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Navelbine in Metastatic Solid Tumors
NCT00278070Phase 2Completed
- Sponsor
- HeCOG
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vinorelbine in breast cancer, non-small cell lung cancer (NSCLC) and prostate cancer (PCa), sponsored by HeCOG. Started Jan 2006; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancernon-small cell lung cancer (NSCLC)prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00278070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278070.